Sign in
4

Changes in Ownership

Outlook Therapeutics, Inc. Filed Acc 0001209191-18-056074

Options or other derivatives

  • SVP Bus. Strat. & Dev. acquired 200,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

MCANDREW STEPHEN J · SVP Bus. Strat. & Dev.

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2018-10-22 Grant or award : show line 1 in the form Stock Option (Right to Buy) +200,000 $0.90 2028-10-22 200,000 200,000 D
Loading xslF345X03/doc4.xml…